Business Daily.
.
A+ R A-

Helsinn and Chugai Pharma Marketing Enter into Agreement for Rights of Anamorelin, Currently in Development for Treatment of Anorexia-Cachexia Syndrome Related to Non-small Cell Lung Cancer in top EU Markets

Author: Australian Business
E-mail Print PDF
LUGANO, Switzerland, November 12, 2013 /PRNewswire/ -- Swiss Pharma Group Helsinn seals an alliance with Japanese company Chugai by granting exclusive distribution & licensing rights to commercialize its innovative phase III ghrelin receptor agonist in Germany,......
More...

More Articles...

Page 492 of 2067

Business Daily Media